Federal contract award
75N92B20F00001
GEMINI BIOPRODUCTS:1110293 [20-003859] - THIS FETAL BOVINE SERUM IS REQUIRED TO CULTURE PRIMARY CELLS AND CELL LINE THAT ARE DONE IN OMBRELLO LAB.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NIH NIAMS |
| NAICS | 325414 — Biological Product (except Diagnostic) Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | HHSN263201500189B |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $10.2K |
| Current contract value | $10.2K |
| Potential contract value / ceiling | $10.2K |
| Start date | Aug 27, 2020 |
| Current end date | Mar 26, 2025 |
| Potential end date | Mar 26, 2025 |
| Latest award activity | Mar 27, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Mar 27, 2025 | P00001 | $-64 | GEMINI BIOPRODUCTS:1110293 [20-003859] - THIS FETAL BOVINE SERUM IS REQUIRED TO CULTURE PRIMARY CELLS AND CELL LINE THAT ARE DONE IN OMBRELLO LAB. |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.